EUVIMEDEUVIMED entdecken
Open Access

Breast Cancer in Users of Levonorgestrel-Releasing Intrauterine Systems

Lina Steinrud Mørch, Amani Meaidi, Giulia Corn, Marie Hargreave, Charlotte Wessel Skovlund

JAMA · 12.11.2024 · 332 (18) · 1578

DOI: 10.1001/jama.2024.18575 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA, erschienen am 12.11.2024. Verfasst von Lina Steinrud Mørch und 4 weiteren Autor:innen. Beteiligte Einrichtung: Cancer and Medicine, The Danish Cancer Institute, Copenhagen, Denmark. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 6 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study uses data from nationwide Danish registries to assess breast cancer risk with continuous use of levonorgestrel-releasing intrauterine systems, accounting for other hormonal exposures.

Autor:innen und Institutionen

  • Cancer and Medicine, The Danish Cancer Institute, Copenhagen, Denmark.
  • Statistics and Data Analysis, The Danish Cancer Institute, Copenhagen, Denmark.
  • Virus, Lifestyle and Genes, The Danish Cancer Institute, Copenhagen, Denmark.

Zitieren

APA

Mørch, L. S., Meaidi, A., Corn, G., Hargreave, M., & Wessel Skovlund, C. (2024). Breast Cancer in Users of Levonorgestrel-Releasing Intrauterine Systems. JAMA, 332(18), 1578. https://doi.org/10.1001/jama.2024.18575

Vancouver

Mørch LS, Meaidi A, Corn G, Hargreave M, Wessel Skovlund C. Breast Cancer in Users of Levonorgestrel-Releasing Intrauterine Systems. JAMA. 2024;332(18):1578. doi:10.1001/jama.2024.18575

BibTeX
@article{Mrch2024,
  author = {Mørch, Lina Steinrud and Meaidi, Amani and Corn, Giulia and Hargreave, Marie and Wessel Skovlund, Charlotte},
  title = {Breast Cancer in Users of Levonorgestrel-Releasing Intrauterine Systems},
  journal = {JAMA},
  year = {2024},
  volume = {332},
  number = {18},
  pages = {1578},
  doi = {10.1001/jama.2024.18575}
}
Kostenlos starten →